320 related articles for article (PubMed ID: 10636214)
1. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.
Egesel T; Büyükasik Y; Dündar SV; Gürgey A; Kirazli S; Bayraktar Y
J Clin Gastroenterol; 2000 Jan; 30(1):66-71. PubMed ID: 10636214
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
Janssen HL; Meinardi JR; Vleggaar FP; van Uum SH; Haagsma EB; van Der Meer FJ; van Hattum J; Chamuleau RA; Adang RP; Vandenbroucke JP; van Hoek B; Rosendaal FR
Blood; 2000 Oct; 96(7):2364-8. PubMed ID: 11001884
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India.
Sharma A; Singh K; Biswas A; Ranjan R; Kishor K; Kumar R; Pandey H; Kamal VK; Saxena R
J Thromb Thrombolysis; 2017 Feb; 43(2):217-223. PubMed ID: 28063132
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?
Fisher NC; Wilde JT; Roper J; Elias E
Gut; 2000 Apr; 46(4):534-9. PubMed ID: 10716684
[TBL] [Abstract][Full Text] [Related]
6. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
Simkova M; Simko F; Kovacs L
Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
[TBL] [Abstract][Full Text] [Related]
7. [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
Jastrzebska M; Bałszan-Kowalska I; Ciechanowicz A; Bińczak-Kuleta A; Falkowski A; Chełstowski K
Pol Arch Med Wewn; 2003 Jun; 109(6):579-88. PubMed ID: 14567090
[TBL] [Abstract][Full Text] [Related]
8. Retinal vascular occlusion and deficiencies in the protein C pathway.
Greiner K; Hafner G; Dick B; Peetz D; Prellwitz W; Pfeiffer N
Am J Ophthalmol; 1999 Jul; 128(1):69-74. PubMed ID: 10482096
[TBL] [Abstract][Full Text] [Related]
9. Portal vein thrombosis in cirrhotics: related with anticardiolipin antibodies?
Oksüzoglu G; Bayraktar Y; Arslan S; Celik I; Arslan M; Sivri B; Kirazli S; Kayhan B
Hepatogastroenterology; 2003; 50(53):1527-30. PubMed ID: 14571778
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilia testing in patients with portal vein thrombosis.
Kirkeby MH; Larsen JB; Grønbaek H; Hvas AM
Scand J Clin Lab Invest; 2020 Dec; 80(8):694-698. PubMed ID: 33026843
[TBL] [Abstract][Full Text] [Related]
12. Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays.
Galli M; Duca F; Ruggeri L; Finazzi G; Negri B; Moia M
Thromb Haemost; 1998 Aug; 80(2):246-9. PubMed ID: 9716147
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of "APTT vs RVVT" based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation.
Baig MA
Indian J Pathol Microbiol; 2020; 63(2):247-250. PubMed ID: 32317524
[TBL] [Abstract][Full Text] [Related]
15. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India.
Bhattacharyya M; Makharia G; Kannan M; Ahmed RP; Gupta PK; Saxena R
Am J Clin Pathol; 2004 Jun; 121(6):844-7. PubMed ID: 15198356
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein.
Egesel T; Unsal I; Bayraktar Y
Turk J Gastroenterol; 2002 Jun; 13(2):89-93. PubMed ID: 16378283
[TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden is not commonly associated with idiopathic portal vein thrombosis in southern India.
Koshy A; Jeyakumari M
Indian J Gastroenterol; 2006; 25(3):140-2. PubMed ID: 16877827
[TBL] [Abstract][Full Text] [Related]
18. Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden).
Piñar A; Saenz R; Rebollo J; Gomez-Parra M; Carrasco F; Herrerias JM; Jimenez-Saenz M
J Clin Gastroenterol; 1998 Dec; 27(4):361-3. PubMed ID: 9855272
[TBL] [Abstract][Full Text] [Related]
19. Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay.
Amiral J; Vissac AM; Seghatchian J
Transfus Apher Sci; 2017 Dec; 56(6):906-913. PubMed ID: 29162399
[TBL] [Abstract][Full Text] [Related]
20. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
